Early-Life Adversity and Dysregulation of Adult Diurnal Cortisol Rhythm.


Journal

The journals of gerontology. Series B, Psychological sciences and social sciences
ISSN: 1758-5368
Titre abrégé: J Gerontol B Psychol Sci Soc Sci
Pays: United States
ID NLM: 9508483

Informations de publication

Date de publication:
01 01 2019
Historique:
received: 31 07 2017
pubmed: 31 8 2018
medline: 29 10 2019
entrez: 31 8 2018
Statut: ppublish

Résumé

Exposure to life stresses can lead to diminution in the capacity of stress response systems to mount a robust response to new challenges, with blunting of dynamic range-the spread between maximal attainable and minimal resting levels. We investigate the association between early-life adversity and the dynamic range of adult diurnal cortisol secretion. In 35- to 86-year-old adults, cortisol assayed from 16 saliva samples over 4 consecutive days was used to compute diurnal dynamic range and area under the curve (AUC). Economic adversity in childhood was indexed by recalled parental education, family welfare dependence, and perceived financial status; and childhood social adversity by parental separation, death, and abuse. Adjusted for age, gender, and race/ethnicity, both childhood adversities were strongly associated with smaller adult cortisol diurnal dynamic range, but not with AUC. The association with cortisol dynamic range was explained by adult social and economic variables. Early-life adversity appears to leave a long-term imprint on cortisol secretion dynamics, reducing diurnal dynamic range without increasing total secretion. This points to the importance of examining the adaptation capacity of physiological systems when studying the impact of early-life and chronic stresses on adult health.

Identifiants

pubmed: 30165409
pii: 5085183
doi: 10.1093/geronb/gby097
pmc: PMC6612015
doi:

Substances chimiques

Hydrocortisone WI4X0X7BPJ

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

160-169

Subventions

Organisme : NIA NIH HHS
ID : U24 AG047867
Pays : United States
Organisme : NCRR NIH HHS
ID : M01 RR000865
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG028748
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG017265
Pays : United States
Organisme : NIA NIH HHS
ID : P01 AG020166
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG047154
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG019239
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG033067
Pays : United States
Organisme : NIA NIH HHS
ID : U19 AG051426
Pays : United States
Organisme : Biotechnology and Biological Sciences Research Council
Pays : United Kingdom

Références

Neurobiol Aging. 2002 Sep-Oct;23(5):921-39
pubmed: 12392796
Psychosom Med. 2006 Jan-Feb;68(1):41-50
pubmed: 16449410
Biodemography Soc Biol. 2009;55(2):219-37
pubmed: 20183906
Dev Psychopathol. 2001 Summer;13(3):515-38
pubmed: 11523846
Psychosom Med. 2010 Oct;72(8):755-62
pubmed: 20841563
Psychosom Med. 2015 Feb-Mar;77(2):176-85
pubmed: 25650548
Int J Psychophysiol. 2013 Oct;90(1):1-7
pubmed: 23454029
Arch Intern Med. 1993 Sep 27;153(18):2093-101
pubmed: 8379800
Dev Psychol. 2003 Sep;39(5):924-33
pubmed: 12952404
J Adolesc Health. 2007 Jul;41(1):3-13
pubmed: 17577528
Psychosom Med. 1999 Mar-Apr;61(2):197-204
pubmed: 10204973
Psychoneuroendocrinology. 2006 Apr;31(3):312-24
pubmed: 16274933
Psychoneuroendocrinology. 2013 Sep;38(9):1658-67
pubmed: 23433749
Dev Psychopathol. 2011 Aug;23(3):939-54
pubmed: 21756443
Ann N Y Acad Sci. 1997 Jan 15;807:419-28
pubmed: 9071367
Science. 1969 Dec 19;166(3912):1480-6
pubmed: 17655041
Ann N Y Acad Sci. 1994 Nov 30;746:22-31; discussion 31-2, 64-7
pubmed: 7825879
Int J Behav Med. 2006;13(3):193-200
pubmed: 17078769
Psychol Bull. 2011 Nov;137(6):959-97
pubmed: 21787044
Psychol Sci. 2016 Sep;27(9):1249-65
pubmed: 27481911
G Ital Med Lav Ergon. 2006 Jan-Mar;28(1 Suppl 1):34-42
pubmed: 19031555
Biol Psychiatry. 2007 Nov 15;62(10):1080-7
pubmed: 17662255
Psychoneuroendocrinology. 2012 Nov;37(11):1755-68
pubmed: 22475549
Psychiatry Clin Neurosci. 2001 Feb;55(1):71-4
pubmed: 11235861
Exp Neurol. 2012 Jan;233(1):12-21
pubmed: 21281629
Stress. 2006 Sep;9(3):143-52
pubmed: 17060048
J Gerontol A Biol Sci Med Sci. 2008 Feb;63(2):190-5
pubmed: 18314456
Psychoneuroendocrinology. 2010 Jul;35(6):932-43
pubmed: 20116177
Psychoneuroendocrinology. 2007 Aug;32(7):824-33
pubmed: 17644268
Child Dev. 2010 Jan-Feb;81(1):252-69
pubmed: 20331666
Int J Psychophysiol. 2009 Apr;72(1):67-73
pubmed: 18854200
Dev Psychopathol. 2011 Nov;23(4):1167-86
pubmed: 22018088
Psychol Bull. 2007 Jan;133(1):25-45
pubmed: 17201569
J Clin Endocrinol Metab. 1998 Jun;83(6):1853-9
pubmed: 9626108
Int J Psychophysiol. 2013 Oct;90(1):21-7
pubmed: 23046585
Psychoneuroendocrinology. 2005 Jul;30(6):568-76
pubmed: 15808926
Psychoneuroendocrinology. 2015 Jan;51:296-306
pubmed: 25462902
Nat Neurosci. 2013 Jun;16(6):698-705
pubmed: 23624512
Yale J Biol Med. 2002 Jul-Aug;75(4):199-205
pubmed: 12784969
Biol Psychiatry. 2012 Feb 15;71(4):344-9
pubmed: 22112928
Arch Pediatr Adolesc Med. 2009 Dec;163(12):1135-43
pubmed: 19996051
J Clin Endocrinol Metab. 2011 May;96(5):1478-85
pubmed: 21346074
Brain Behav Immun. 2013 Mar;30 Suppl:S163-70
pubmed: 22884416
Psychoneuroendocrinology. 2013 Nov;38(11):2585-97
pubmed: 23831263

Auteurs

Arun S Karlamangla (AS)

Division of Geriatrics, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California.

Sharon Stein Merkin (SS)

Division of Geriatrics, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California.

David M Almeida (DM)

Department of Human Development and Family Studies, Pennsylvania State University, University Park.

Esther M Friedman (EM)

RAND Corporation, Santa Monica, California.

Jacqueline A Mogle (JA)

College of Nursing, Pennsylvania State University, University Park.

Teresa E Seeman (TE)

Division of Geriatrics, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH